Although there are no clinically meaningful prognostic or predictive cancer biomarkers available, a series of potential biomarkers have been identified, for example, in the blood (VEGF), on the cell surface (epithelial growth factor receptor 1 (EGFR)), and in the cell nucleus (BRCA1, BRCA2) [32]. This evidence concerns the gene BRCA2 and cancer.